Drug firms unveil price cuts

Aid agencies welcome move to make life-saving drugs cheaper in the developing world, with caveats.

    A number of leading drug firms have announced plans to cut prices dramatically for life-saving drugs in the developing world.

    UK-based Glaxo Smithkline, says it will reduce the cost of its Rotarix vaccine by 67 per cent. It will now cost $5 to immunise a child against rotavirus, a leading cause of diarrhoea.

    The price cuts have been broadly welcomed by aid agencies. But Save the Children says it only goes partly in plugging a $3.7bn shortfall needed to produce life-saving drugs.

    Al Jazeera spoke to Paul Cook, the head of advocacy at Tearfund.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    Interactive: Plundering Cambodia's forests

    Interactive: Plundering Cambodia's forests

    Meet the man on a mission to take down Cambodia's timber tycoons and expose a rampant illegal cross-border trade.

    The priceless racism of the Duke of Edinburgh

    The priceless racism of the Duke of Edinburgh

    Prince Philip has done the world an extraordinary service by exposing the racist hypocrisy of "Western civilisation".

    China will determine the future of Venezuela

    China will determine the future of Venezuela

    There are a number of reasons why Beijing continues to back Maduro's government despite suffering financial losses.